According to a recent LinkedIn post from Plexāā | Creators of BLOOM⁴³, the company plans to attend The Aesthetic Society’s Aesthetic Meet 2026 in May. The post notes that CEO and founder Dr. Saahil Mehta and U.S. Patient Champion Nichole Wenderlich Owens, M.B.A., intend to engage with clinicians on the role of pre-surgery preparation in supporting patient outcomes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights a focus on breast surgery, prehabilitation, patient care, and medtech solutions. For investors, participation in a major aesthetics industry event may signal efforts to deepen clinical relationships, position BLOOM⁴³ within surgical care pathways, and potentially drive future adoption opportunities in the aesthetic surgery market.